• July 7, 2017

MIROCALS – FIRST PARTICIPANT RECRUITED

The MIROCALS (Modifying Immune Response and Outcomes in ALS) clinical trial, jointly funded by the MND Association and the European Union Horizon 2020, has recruited its first participant at Hospices Civils de Lyon, France.

For further information and support contact our MND Connect helpline

mndconnect 0808 802 6262